Page 24 - Read Online

Page 12 of 16 Zhang et al. Hepatoma Res 2020;6:30 I http://dx.doi.org/10.20517/2394-5079.2020.17

management, including radiology, genetics, molecular pathology and histopathology would result in a more
accurate and reliable diagnosis for predicting the prognosis of HCC.

DECLARATIONS
Authors’ contributions
Made substantial contributions to the conception and design of the study, and performed data analysis and
interpretation: Zhang Y, Huang ZX, Chen J
Performed data acquisition, as well as provided administrative, technical, and material support: Shi YJ, Jiang
HY, Cao LK, Song B

Availability of data and materials
Not applicable.

Financial support and sponsorship
This work was supported by grants from the Research Grant of National Nature Science Foundation of China
(Grant number 81771797), Science and Technology Support Program of Sichuan Province (Grant number
2017SZ0003), and the 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University
(Grant number ZYJC18008).

Conflicts of interest
All authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2020.

REFERENCES
1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and
mortality worldwide for 36 cancers in 185 countries. Int J Cancer 2018;68:394-424.
2. Selcuk H. Prognostic factors and staging systems in hepatocellular carcinoma. Exp Clin Transplant 2017;15:45-9.
3. Farinati F, Vitale A, Spolverato G, Pawlik TM, Huo TL, et al. Development and Validation of a new prognostic system for patients with
hepatocellular carcinoma. PLoS Med 2016;13:e1002006.
4. Rodríguez-Perálvarez M, Luong TV, Andreana L, Meyer T, Dhillon AP, Burroughs AK. A systematic review of microvascular invasion in
hepatocellular carcinoma: diagnostic and prognostic variability. Ann Surg Oncol 2013;20:325-9.
5. Sohn JH, Duran R, Zhao Y, Fleckenstein F, Chapiro J, et al. Validation of the Hong Kong liver cancer staging system in determining
prognosis of the North American patients following intra-arterial therapy. Clin Gastroenterol Hepatol 2017;15:746-55.e4.
6. Martins-Filho SN, Paiva C, Azevedo RS, Alves VAF. Histological grading of hepatocellular carcinoma-a systematic review of literature.
Front Med (Lausanne) 2017;10:193.
7. Degasperi E, Colombo M. Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease. Lancet Gastroenterol
Hepatol 2016;1:156-64.
8. Coskun M. Hepatocellular carcinoma in the cirrhotic liver: evaluation using computed tomography and magnetic resonance imaging. Exp
Clin Transplant 2017;15:36-44.
9. Yoneda N, Matsui O, Kobayashi S, Kitao A, Kozaka K, et al. Current status of imaging biomarkers predicting the biological nature of
hepatocellular carcinoma. Jpn J Radiol 2019;37:191-208.
10. Hu HT, Shen SL, Wang Z, Shan QY, Huang XW, et al. Peritumoral tissue on preoperative imaging reveals microvascular invasion in
hepatocellular carcinoma: a systematic review and meta-analysis. Abdom Radiol (NY) 2018;43:3324-30.
11. Ayuso C, Rimola J, Vilana R, Burrel M, Darnell A, et al. Diagnosis and staging of hepatocellular carcinoma (HCC): current guidelines.
Eur J Radiol 2018;101:72-81